HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

Steven Schnelle

Subscribe to Steven Schnelle's Posts
Steven Schnelle delivers strategic solutions to investors and business operators in the healthcare and life sciences industries. He advises a full spectrum of investors, healthcare and life sciences organizations, providing insight for clients navigating the complex legal structures defining these tightly regulated sectors. Learn more about Steven's practice here.

HRSA Issues Notice Confirming 340B Registration Requirement


By , and on Oct 27, 2023
Posted In 340B

On October 26, the Health Resources and Services Administration (HRSA) published a Federal Register notice addressing the use of 340B drugs at off-campus hospital outpatient locations that have not yet appeared on a filed Medicare cost report. These locations are known as “unregistered child sites.” In the notice, HRSA maintains that its prior policy allowing...

Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm